← Back to Screener
Cosmos Holdings Inc. Common Stock (COSM)
Price$0.25
Value ScoreD
Growth ScoreB
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-76.32%
Price vs S&P 500 (4W)-39.90%
VGM Score46.32
Market Capitalization$14.81M
All Metrics
Book Value / Share (Quarterly)$0.45
P/TBV (Annual)1.72x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.04%
Cash Flow / Share (Quarterly)$-0.21
Price vs S&P 500 (YTD)-61.34%
Gross Margin (TTM)12.10%
Net Profit Margin (TTM)-29.33%
EPS (TTM)$-0.59
10-Day Avg Trading Volume1.04M
EPS Excl Extra (TTM)$-0.59
Revenue Growth (5Y)3.33%
EPS (Annual)$-0.63
ROI (Annual)-50.65%
Gross Margin (Annual)12.10%
Net Profit Margin (5Y Avg)-27.08%
Cash / Share (Quarterly)$0.02
Revenue Growth QoQ (YoY)38.52%
ROA (Last FY)-29.24%
Revenue Growth TTM (YoY)19.93%
EBITD / Share (TTM)$-0.50
ROE (5Y Avg)-87.59%
Operating Margin (TTM)-25.49%
Cash Flow / Share (Annual)$-0.21
P/B Ratio0.80x
P/B Ratio (Quarterly)1.01x
Net Income / Employee (Annual)$-117,500
EV / Revenue (TTM)0.51x
Net Interest Coverage (TTM)-7.41x
ROA (TTM)-30.15%
EV / EBITDA (TTM)55.78x
EPS Incl Extra (Annual)$-0.63
Current Ratio (Annual)1.00x
Quick Ratio (Quarterly)0.68x
3-Month Avg Trading Volume0.92M
52-Week Price Return-44.12%
Revenue / Employee (TTM)$400,400
Tangible BV / Share (Quarterly)$0.26
P/S Ratio (Annual)0.23x
Asset Turnover (Annual)1.00x
52-Week High$1.32
Operating Margin (5Y Avg)-21.70%
EPS Excl Extra (Annual)$-0.63
CapEx CAGR (5Y)4.95%
26-Week Price Return-60.39%
Quick Ratio (Annual)0.68x
13-Week Price Return-36.65%
Total Debt / Equity (Annual)1.05x
Current Ratio (Quarterly)1.00x
Enterprise Value$33.47M
Revenue / Share Growth (5Y)-53.99%
Asset Turnover (TTM)1.03x
Book Value / Share Growth (5Y)-47.21%
Revenue / Employee (Annual)$400,400
Inventory Turnover (Annual)11.32x
Pretax Margin (Annual)-29.33%
Cash / Share (Annual)$0.02
3-Month Return Std Dev72.17%
Gross Margin (5Y Avg)10.96%
Net Income / Employee (TTM)$-117,500
ROE (Last FY)-103.91%
Net Interest Coverage (Annual)-3.25x
EPS Basic Excl Extra (Annual)$-0.63
P/FCF (TTM)28.98x
Receivables Turnover (TTM)3.55x
Total Debt / Equity (Quarterly)1.05x
EPS Incl Extra (TTM)$-0.59
Receivables Turnover (Annual)3.55x
ROI (TTM)-47.66%
P/S Ratio (TTM)0.23x
Pretax Margin (5Y Avg)-26.74%
Revenue / Share (Annual)$2.15
Tangible BV / Share (Annual)$0.26
Forward P/E7.41x
Price vs S&P 500 (52W)-72.32%
Year-to-Date Return-50.40%
5-Day Price Return-2.18%
EPS Normalized (Annual)$-0.63
ROA (5Y Avg)-24.71%
Net Profit Margin (Annual)-29.33%
Month-to-Date Return-32.62%
Cash Flow / Share (TTM)$-1.56
EBITD / Share (Annual)$-0.50
Operating Margin (Annual)-25.49%
LT Debt / Equity (Annual)0.32x
ROI (5Y Avg)-37.67%
LT Debt / Equity (Quarterly)0.32x
EPS Basic Excl Extra (TTM)$-0.59
P/TBV (Quarterly)1.72x
P/B Ratio (Annual)1.01x
Inventory Turnover (TTM)11.32x
Pretax Margin (TTM)-29.33%
Book Value / Share (Annual)$0.45
Price vs S&P 500 (13W)-46.40%
Beta4.21x
P/FCF (Annual)2.27x
Revenue / Share (TTM)$1.83
ROE (TTM)-81.69%
52-Week Low$0.25
vGradeD
gGradeB
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q4 25-0.31est. -0.04
Q1 26-0.06est. -0.01
Analyst Recommendations
Feb 2025
Mar 2025
Apr 2025
May 2025
4.14
4.14
4.14
4.14
Industry Peers — Drug Wholesale(9)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
COSMCosmos Holdings Inc. Common Stock | D | B | D | $0.25 |
| MCKMcKesson Corporation | D | B | D | $734.82 |
| CORCencora, Inc. | D | B | D | $264.69 |
| CAHCardinal Health, Inc. | C | C | C | $195.15 |
| HLFHerbalife Ltd. | B | D | C | $11.90 |
| NUSNuSkin Enterprises, Inc. | A | F | D | $5.63 |
| WGRXWellgistics Health, Inc. Common Stock | D | F | F | $3.85 |
| ZSTKZeroStack Corp. Common Stock | — | F | D | $4.77 |
| HWHHWH International Inc. Common Stock | F | F | C | $1.09 |
| HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares | — | F | D | $0.55 |
About
Cosmos Health Inc manufactures and distributes branded and generic pharmaceuticals, over-the-counter medications, and proprietary nutraceutical brands (Sky Premium Life and Mediterranation) through wholesale distributors, wholesalers, and retail healthcare providers. The company operates across four primary segments—Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals, and Other—with the Wholesale segment generating the majority of revenue.